NAVB - .8045 PR out late Wednesday. Pre-market now up to 1.07/1.08. Navidea Biopharmaceuticals Agrees to Sell Lymphoseek to Cardinal Health http://stockcharts.com/c-sc/sc?s=NAVB&p=D&b=5&g=0&i=t46975953141&r=1480082365747 http://stockcharts.com/c-sc/sc?s=NAVB&p=W&b=5&g=0&i=t81936996788&r=1480082349126